论文部分内容阅读
目的:观察在西药治疗的基础上联合三七天麻散治疗不稳定性心绞痛(UAP)临床疗效及对血浆D-二聚体的影响。方法:对照组42例单用单硝酸异山梨酯,治疗组48例联合三七天麻散(每日剂量4.8 g,分3次口服),疗程30 d。结果:治疗组和对照组心绞痛症状总有效率分别为93.7%和73.3%,两组比较有显著性差异(P<0.01);心电图疗效分别为69.1%和54.8%,两组比较有显著性差异(P<0.05);血浆D-二聚体水平治疗组治疗后较治疗前明显下降(P<0.01),与对照组治疗后相比较有显著差异(P<0.01)。结论:三七天麻散对缓解心绞痛症状有一定疗效。
OBJECTIVE: To observe the clinical efficacy of Panaxtiantianmaisan on the treatment of unstable angina pectoris (UAP) and its effect on plasma D-dimer on the basis of western medicine. Methods: In the control group, 42 patients were given isosorbide mononitrate alone, and 48 patients in the treatment group were treated with Panaxadi Tianma San (daily dose of 4.8 g, orally 3 times) for 30 days. Results: The total effective rates of angina pectoris in the treatment group and the control group were 93.7% and 73.3% respectively, with significant difference between the two groups (P <0.01); the curative effect of electrocardiogram was 69.1% and 54.8% respectively, there was significant difference between the two groups (P <0.05). The level of plasma D-dimer in treatment group after treatment was significantly lower than that before treatment (P <0.01), which was significantly different from that in control group after treatment (P <0.01). Conclusion: Panax Tianma Powder can relieve the symptoms of angina effectively.